Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: J Mol Cell Cardiol. 2012 Jan 3;52(3):596–607. doi: 10.1016/j.yjmcc.2011.12.012

Table 3.

Genetically modified mice in the study of the KATP channel.

Transgenesis
Subunit
targeted
Type of
modification
Cell type
targeted
Functions modified/studied References

Kir6.2 Pore mutant Pancreatic Pancreatic β-cell function [108109]
Kir6.1, Kir6.2 Pore mutant Cardiac Exercise stress, KATP activity [59]
Kir6.2 ATP insensitive Cardiac Cardiovascular function [110]
SUR1, SUR2A Overexpression Cardiac Cardiovascular function [111]
Kir6 Pore mutant Endothelial Hypertension, endothelial endothelin-1 release [112]
Kir6 Pore mutant Smooth muscle Energetics [113]

Gene targeting
Subunit
targeted
Total number of
exons
Exon(s)
targeted
Functions modified/studied References

Kir6.1 3 3rd Vascular [114]
Kir6.2 1 1st Stress, ischemic preconditioning, insulin release [115117]
SUR1 39 1st Insulin release [118]
SUR1 39 2nd Insulin release, cardiac ischemia, atrial KATP [52, 119120]
SUR2 41 12th to 16th Vascular, cardiac ischemia [65, 121123]

Exons are numbered according to the cited references.